Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000152009 | SCV000053215 | benign | not specified | 2021-07-27 | criteria provided, single submitter | clinical testing | Variant summary: TGFBR2 c.1159G>T (p.Val387Leu) results in a conservative amino acid change located in the Serine-threonine/tyrosine-protein kinase, catalytic domain (IPR001245) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00035 in 250480 control chromosomes in the gnomAD database, including 1 homozygote. The observed variant frequency is approximately 112-fold of the estimated maximal expected allele frequency for a pathogenic variant in TGFBR2 causing Loeys-Dietz Syndrome phenotype (3.1e-06), strongly suggesting that the variant is benign. p.Val387Leu has been reported in the literature in individuals affected with Marfan Syndrome (MFS), Loeys-Dietz Syndrome (LDS) or Thoracic Aortic Aneurysms and Dissections (TAAD) (Matyas_2006, Stheneur_2008, Lerner-Ellis_2014), while it was also reported in a case of Brain arteriovenous malformation (Scimone_2020). Two of these studies reported the variant as likely benign or polymorphism. These reports do not provide unequivocal conclusions about association of the variant with Loeys-Dietz Syndrome. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four ClinVar submitters (evaluation after 2014) cite the variant as benign/likely benign and two ClinVar submitters (evaluation after 2014) cite it as uncertain significance. Based on the evidence outlined above, the variant was classified as benign. |
Laboratory for Molecular Medicine, |
RCV000152009 | SCV000200575 | likely benign | not specified | 2010-08-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001703428 | SCV000250936 | likely benign | not provided | 2020-09-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 18781618, 16791849, 17061023, 24793577) |
Genomic Diagnostic Laboratory, |
RCV000030544 | SCV000296973 | uncertain significance | Loeys-Dietz syndrome | 2015-09-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000249454 | SCV000319271 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-09-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Centre for Mendelian Genomics, |
RCV000414949 | SCV000492956 | uncertain significance | Ascending tubular aorta aneurysm; Vascular dilatation | 2014-05-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000249454 | SCV000548116 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000249454 | SCV000782369 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000249454 | SCV000903193 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-05-07 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002277109 | SCV002566151 | uncertain significance | Ehlers-Danlos syndrome | 2020-02-01 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000249454 | SCV003838805 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2021-08-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004754278 | SCV005362568 | likely benign | TGFBR2-related disorder | 2024-04-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |